Trial intelligence / Profile preview

Low-dose azathioprine + allopurinol vs azathioprine monotherapy in ulcerative colitis

2016-002433-30Phase 3Completed

Sponsor
Copenhagen University Hospital - Hvidovre
Start
Jun 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial in autoimmune colitis comparing Azathioprine monotherapy with Low-dose azathioprine + allopurinol (2 arms). Primary endpoint: Steroid- and biologic-free remission by total Mayo score. Started Jun 2016; status: completed.

02

Drugs

azathioprineallopurinol
03

Conditions

autoimmune colitis

Beyond the preview

Go deeper on 2016-002433-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-002433-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call